Bolt Biotherapeutics, Inc. financial data

Symbol
BOLT on Nasdaq
Location
900 Chesapeake Drive, Redwood City, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 324 % -29.2%
Debt-to-equity 86.4 % +101%
Return On Equity -97.6 % -40.5%
Return On Assets -52.4 % -7.85%
Operating Margin -884 % -13.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.92M shares -95%
Common Stock, Shares, Outstanding 1.92M shares -95%
Entity Public Float 21.9M USD -31.8%
Common Stock, Value, Issued 0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 1.92M shares +0.36%
Weighted Average Number of Shares Outstanding, Diluted 1.92M shares +0.36%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.2M USD -46.9%
Research and Development Expense 35.3M USD -43.2%
General and Administrative Expense 14.6M USD -27%
Operating Income (Loss) -45.9M USD +39.5%
Nonoperating Income (Expense) 3.26M USD -69.8%
Net Income (Loss) Attributable to Parent -42.7M USD +34.4%
Earnings Per Share, Basic 9 USD/shares +53.1%
Earnings Per Share, Diluted 9 USD/shares +53.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 17.8M USD +89.5%
Cash, Cash Equivalents, and Short-term Investments 38.8M USD -54%
Assets, Current 35.6M USD -37.7%
Property, Plant and Equipment, Net 1.5M USD -57.9%
Operating Lease, Right-of-Use Asset 19.9M USD +18.7%
Other Assets, Noncurrent 179K USD -37.6%
Assets 65.1M USD -40.5%
Accounts Payable, Current 1.52M USD +2.43%
Employee-related Liabilities, Current 1.93M USD -40.6%
Liabilities, Current 9.97M USD -44.9%
Operating Lease, Liability, Noncurrent 20.9M USD +36.1%
Other Liabilities, Noncurrent 133K USD
Liabilities 33M USD -11.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -10K USD -105%
Retained Earnings (Accumulated Deficit) -454M USD -10.4%
Stockholders' Equity Attributable to Parent 32.1M USD -55.4%
Liabilities and Equity 65.1M USD -40.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.4M USD +20.2%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 14.6M USD +42.6%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 1.92M shares -95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.19M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.5M USD +75.2%
Deferred Tax Assets, Valuation Allowance 96.9M USD +15.8%
Deferred Tax Assets, Gross 103M USD +15.3%
Operating Lease, Liability 23.6M USD +29.8%
Depreciation 100K USD -96.9%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -42.9M USD +33.7%
Lessee, Operating Lease, Liability, to be Paid 32.8M USD +26.8%
Property, Plant and Equipment, Gross 8.63M USD -17.1%
Operating Lease, Liability, Current 2.7M USD -4.39%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.58M USD +60.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.4M USD +24.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +8.85%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.26M USD +19.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.78M USD +60.3%
Deferred Tax Assets, Operating Loss Carryforwards 53.5M USD +13%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 23.8M USD +27.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.97M USD +60.4%
Operating Lease, Payments 1.24M USD +3.41%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 399K USD -12.9%
Deferred Tax Assets, Net of Valuation Allowance 6.51M USD +8.79%
Share-based Payment Arrangement, Expense 2.92M USD -64.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%